0001437749-23-017046.txt : 20230609 0001437749-23-017046.hdr.sgml : 20230609 20230609152613 ACCESSION NUMBER: 0001437749-23-017046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230608 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schoenberg Mark CENTRAL INDEX KEY: 0001763581 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 231004999 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 9 HA TA ASIYA STREET CITY: RA ANANA STATE: L3 ZIP: 4365007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 rdgdoc.xml FORM 4 X0407 4 2023-06-08 0001668243 UroGen Pharma Ltd. URGN 0001763581 Schoenberg Mark 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 Chief Medical Officer 0 Restricted Stock Units 2023-06-08 4 A 0 30000 0 A Ordinary Shares 30000 30000 D Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2023. /s/ Jason D. Smith, Attorney-in-Fact 2023-06-09